Rare Diseases: Rare but not alone
We are committed to listen and learn from patients with rare diseases to deliver breakthrough therapies. Click here to find out more about our work.
Search
We are independent, family-owned
At Boehringer Ingelheim we are independent, family-owned and intend to remain so. Click here to discover how we live our Leitbild and learn more.
Supporting Fundappas
Fundappas is the first school of guide and assistance dogs in Uruguay. We support Fundappas to improve the quality of life of dogs and people. Learn more.
Supporting local communities by offsetting carbon emissions
Boehringer Ingelheim supports carbon emissions reduction projects by partnering with ClimateSeed. Click here to find out more information about this.
COVID-19 Boehringer Ingelheim Clinical Trials
We are doing everything we can to limit the impact COVID-19 could have on our clinical trial programs. Click here to find out and learn more.
How pets made the pandemic bearable?
Lockdown wasn’t easy but having us work from home was certainly delightful for our pets. Learn some insights from the APPA COVID-19 Pulse Study.
Our Purpose
Find out what 'transforming lives' and 'for generations' means for our work and long-term thinking here. Click here to learn more about our purpose.
Our Ambition 2025
Boehringer Ingelheim’s commitment to serve humankind can be met if we are the preferred partner and admired competitor in three areas. Learn more here.
World Recycling Day: Closing the Loop
Transitioning the economy from a linear to a circular approach is a herculean task – but also an innovation that carries huge potential. Learn more here.
EMPEROR-Preserved trial reveals that Empagliflozin reduces the risk of hospitalization for heart-failure and cardiovascular death
EMPEROR-Preserved trial reveals that Empagliflozin reduces the risk of hospitalisation for heart-failure and cardiovascular death. Find out more here.
Boehringer Ingelheim India’s stroke awareness campaign enters the GUINNESS WORLD RECORDS™
Boehringer Ingelheim India’s stroke awareness campaign enters the GUINNESS WORLD RECORDS™. Click here to read the press release and find out more.
Our Employees
We offer our employees demanding and challenging tasks. Boehringer Ingelheim needs employees who innovate. Learn more about our employees here.
Stroke Risk Factors Symptoms
Suffering a stroke is one of the most devastating medical emergencies that can happen to a person. Find out more about risk factors and symptoms.
What can the patient do?
Be aware and know your source.
EHS management approach
Our comprehensive EHS framework describes our EHS management system at a corporate level consisting of four elements. Click here to find out more.
Production Insights
Boehringer Ingelheim makes an important contribution to the reliable and sustainable supply of pharmaceuticals. Click here to learn and find out more.
Type 2 Diabetes and Risk of Viral Infections
In the current COVID-19 climate, it’s important for everyone to stay safe at home, particularly people living with conditions such as type-2 diabetes.
Webinars for clinicians on needs of vulnerable respiratory
Webinars with more than 1,000 HCPs to provide an update on prevention and treatment recommendations for vulnerable respiratory patients. Learn more here.
In France, it’s time to be(e)
How about producing honey and contributing to environmental sustainability during your work hours? Click here to read more about this story.
Boehringer Ingelheim receives ad-interim injunctions against four more domestic pharma companies for patent infringement of its anti-diabetes drug
Boehringer Ingelheim receives ad-interim injunctions against four more domestic pharma companies for patent infringement of its anti-diabetes drug.
Protecting our pets from parasites
If you think that keeping your pets indoors will keep them safe from parasites, think again! Learn more about protecting your pets from parasites.
Stroke, Don’t Stay at Home
During COVID-19, there was a decrease in stroke hospital admissions. Learn why it is crucial that patients can still access urgent care at this time.
Expectations towards our business partners
Boehringer Ingelheim utilises an extensive network of international suppliers. Click here to learn more about our expectations towards our suppliers.
Waste
Resource conservation at Boehringer Ingelheim is managed as part of an ongoing process of prevention and reduction of material usage and waste. Learn more.
COVID-19 USA Partnership ensures jobs & feeds community
Boehringer Ingelheim & partners feed the hungry, first responders and manufacturing employees still working onsite. Click here to learn more.